The Beijing Truce

MS Blogs
May 26
11 min read

The Room That Explains Everything

On May 12, 2026, Beijing's airport offered an image no press release could have staged better. Stepping off the plane alongside American trade officials were Tim Cook of Apple, Jensen Huang of Nvidia, and Elon Musk of Tesla not as observers, but as participants. Inside China's most prestigious government building, these CEOs stood beside American ministers as they were introduced to President Xi Jinping.

The summit happened because 2025 had been expensive for everyone. The US and China had spent the year taxing each other's goods heavily, America at 145%, China at 125%, and over $650 billion in trade was thrown into chaos. Supply chains for computer chips, medicines, and everyday consumer goods all took hits, and American consumers felt it directly, with inflation climbing back above 4% by late 2025. A temporary tariff ceasefire in Geneva and a follow-up agreement in London had stabilized things, but only partially. That framework was set to expire in mid-2026.

The pressure didn't stop there. Since March 2026, the Strait of Hormuz, the narrow waterway through which roughly 20% of the world's oil flows, had been effectively blocked following the escalation of the US-Iran conflict. Energy prices had spiked, and both economies were absorbing the shock in real time. Two governments arrived in Beijing with more urgency than either wanted to show.

What Each Side Wanted, and What They Wouldn't Say

Washington's Agenda

The stated goals were straightforward: restore large-scale agricultural exports, a midterm political imperative, and recover Boeing's position in China's commercial aviation market, where deferred aircraft deliveries and stalled orders since 2022 had weakened the company’s foothold. The US also wanted movement on the Strait of Hormuz. Both sides agreed publicly that the conflict should end and the strait should reopen, but the terms of de-escalation were never announced.

What Washington wouldn't say as clearly — advanced chips:

Jensen Huang's last-minute addition to the delegation told the whole story of where the chip war stands. Trump had authorised H200 sales to China in December 2025, but with a condition Beijing had no intention of accepting: civilian AI use only, military and critical infrastructure explicitly barred, which were not favourable terms for them, in response - China declined to buy a single H200 to avoid any reliance on the US for semiconductors. Nvidia, which once held roughly 95% of the Chinese AI chip market, is now at zero. Meanwhile, China has continued building frontier AI models: DeepSeek V4, Kimi K2.6, GLM 5.1, without the H200 at all. What Washington is trying to use as leverage is a product Beijing has already decided it can live without and is building fast enough to prove it.

Rare earths the same script:

Rare earths followed the same pattern as chips: loud American declarations, Chinese silence, and a ground reality that matched neither. Trump declared the issue "settled" after both Busan in October 2025 and Beijing in May 2026. The White House announced China had agreed to restore access to yttrium, scandium, neodymium, and indium critical inputs for American EVs, semiconductors, and defence. China's readout made no mention of rare earths at all, and exports were still running below 50% pre-restriction levels when Trump's plane left.

The structural reality is simple. China produces roughly 69% of the world's rare earths (against 13% for the US and 7% for Australia) and processes over 85% of global supply. The US is investing in alternatives Project Vault, global co-investment deals, and a $400 million Department of Defense stake in MP Materials taken in July 2025, intended to lift annual magnet capacity from 1,000 to 10,000 metric tons over the next decade. But scale tells the story: China produced an estimated 300,000 tons of magnets in 2024. Even in an optimistic scenario, building a fully integrated US rare earth supply chain takes five to seven years, possibly a decade. If China tightens exports in the interim, prices surge and the rest of the world is forced to accelerate investment it should have made years ago.

Beijing's Agenda

What China said explicitly: Memory Chips: Before the meeting, Chinese officials had quietly informed Washington that Beijing wanted relief on high-bandwidth memory chip restrictions, the specific input Huawei needs to develop competitive AI hardware domestically. It was a precise ask, not a general complaint. China named the component, signalling it understood exactly which chokepoint mattered most.

Taiwan the price of everything: Xi's framing was unambiguous. He told Trump directly that Taiwan was "the most important issue in China-US relations" and that if mishandled, the two countries could face "confrontation or even conflict." This was not a diplomatic boilerplate. It was a structural condition, Beijing signalling that the ceiling on cooperation across trade, technology, and rare earths was set by Washington's Taiwan posture. Everything else was downstream of that.

What wasn't said, but was clearly communicated:

Xi's decision to elevate Taiwan so explicitly was partly strategic timing. The US had recently relocated self-defence weapons originally assigned to Taiwan to theatres involved in the Iran conflict, a reallocation Beijing noticed and chose not to let pass. Washington had also announced an $11.1 billion arms package for Taiwan, the largest to date, weeks before the summit. China's silence on formal deliverables was not an oversight; it was a response. When Washington sells Taiwan its most significant arms package in history and then arrives asking for concessions, Beijing's answer is to make Taiwan the centrepiece and offer nothing it can't quietly walk back on.

The same logic governed rare earths. China never publicly agreed to any formal deal; the White House announced one; Beijing's readout did not. Its dominance in rare earth processing is its most durable structural advantage, and it has no incentive to formalise terms that reduce that leverage. By staying silent while letting Washington claim a win, China kept the squeeze without paying the diplomatic cost of saying no out loud.

What Experts Expected and What Actually

Happened

The summit was anticipated as a potential inflection point. Most analysts called it correctly: modest deliverables, structural issues untouched, and a tone of managed stability rather than genuine reset.

The overall read: The summit produced a mini-deal — a $38B agricultural framework, a 200-plane Boeing order worth approximately $24B, and tariff carve-outs on $30B in non-sensitive consumer goods. These were real outcomes. But this was not a reset. It was two rivals agreeing on the pace of their separation rather than its direction. The working groups, the boards, the frameworks without enforcement all point to the same conclusion: both sides wanted the optics of progress without the constraints of commitment.

The Bill for Twenty-Five Years

China's entry into the WTO in 2001 rested on a theory that deeper economic integration would gradually make China more market-oriented and politically aligned with the global order. The West acted on this belief for two decades, transferring technology, offshoring manufacturing, and providing market access worth trillions in cumulative export revenue.

Beijing used that access differently than the theory predicted. Rather than letting market forces erode state direction, it ran the experiment in reverse, channeling the revenues and technology flows of global integration into the most ambitious state-directed industrial program in modern history. "Made in China 2025" targeted ten strategic sectors for dominance; the "Dual Circulation" strategy formalised the logic of using global markets opportunistically while building domestic self-sufficiency that could survive their closure. Every dollar of Western market access became capital for strategic autonomy.

By 2026, the results were structural. China approximately processes roughly 87% and refines 91% of the world's rare earths, manufactures over 85% of global solar panels, produces at least 60% of lithium-ion battery cells, and supplies over 70% of global active pharmaceutical ingredients. These are not competitive advantages. They are chokepoints and they sit almost entirely in the midstream and downstream of global supply chains, in the processing and assembly steps that turn raw inputs into finished goods. American leverage, by contrast, is concentrated upstream: in chip design tools, intellectual property, and the financial architecture of trade. The West did not lose to a rival system. It funded one, inside the rules-based order it designed itself, and the bill is now visible in every unresolved agenda item from Beijing.

That mutual dependency is precisely why clean separation is impossible for either side, and why managed decoupling, rather than rupture, has become the operative framework. Severing the relationship would cost both sides more than either can absorb.

What the Agreements and Silences Mean for Industry

Agriculture: The new framework and restored beef licences offer short-term relief to US farmers, who needed it — agricultural exports to China were on track to hit just $9 billion in 2026, the lowest since 2007 and down more than 50% from 2022. But the framework arrests a decline it cannot reverse. Brazil's share of China's soybean imports rose to 71% in 2024 while the US share fell to 21%; in 2025, Chinese imports of US soybeans fell 76%, with China not buying a single US cargo during the summer months. This is the endpoint of two decades of deliberate Chinese diversification toward Brazil, Argentina, and ASEAN. A purchase commitment can move numbers for a year, but not reverse the strategic diversification across decades.

Boeing and aerospace: Boeing has had a presence in China for over 50 years, with its aircraft making up roughly half of China's passenger fleet. China was once one of Boeing's most critical markets, contributing around 13% of revenue in 2015 and 2017 and taking nearly 25% of deliveries in 2017. The 2018-19 tariffs changed that, turning commercial aircraft into a geopolitical instrument; China's share of Boeing deliveries collapsed from over 22% in 2017-18 to around 12% in 2019. Boeing now expects China to contribute only 10-12% of future business as COMAC's C919 gradually captures the narrow-body market. The 200-plane order is real, but it papers over a structural decline though Boeing retains a genuine edge in widebody aircraft like the 777X and 787, where China lacks domestic capability and Airbus alone cannot meet demand.

Technology the loudest silence: The absence of any easing on semiconductor and AI restrictions was the summit's strongest signal: the US-China technology split is becoming permanent rather than temporary. Trade may continue in agriculture and aerospace, but advanced technology is separating into two independent ecosystems. This is already driving long-term bets TSMC's Arizona fabs, Intel's subsidised domestic expansion, China’s SMIC's push for alternative Chinese chip capability toward two parallel semiconductor systems with separate supply chains, standards, and compliance regimes.

Tariff architecture: The $30 billion consumer-goods carve-out is short-term inflation relief, not a policy shift. The broader 55% tariff structure on strategic goods EVs, steel, copper, lithium-ion batteries remains unchanged, signalling that protectionism is here to stay. For companies, supply chain diversification is no longer cyclical but structural: businesses are being pushed toward reshoring or relocating to geopolitically aligned countries, with production, quality, and margins all taking near-term hits and no clean solution in sight.

Impact on India If US-China relationships Stabilise

Economic Output: India's manufacturing boom is real but it is running on a geopolitical subsidy that could be withdrawn faster than any PLI scheme can compensate for.

The four industries most exposed share the same structure: high export reliance, deep Chinese supply chain embedding, and price competitiveness that exists only because China currently faces restrictions that are a policy variable, not a permanent condition.

Smartphones (India adds 20 cents of value for every dollar while China adds 45), Solar (90% assembly of imported Chinese cells, costs double without policy protection), Pharmaceuticals (India supplies 61% of US generic drugs the risk is China entering the finished product market), Semiconductors (₹1.60 lakh crore committed, entire investment rationale built on US-China decoupling)

Smartphones: Electronics exports crossed $48.2B in 2025, but $36.8B in components were imported to make them 40% from China. Apple's India shift was driven by $800M in quarterly tariff costs on its China operations. Remove the tariff differential and the business case for absorbing India's higher costs and thinner supplier base collapses immediately.

Solar: US tariffs on Indian modules escalated from 14% to 126% between 2025 and early 2026, causing a 35% collapse in US-bound exports in the first half of 2025, the US accounted for 95% of India's solar export market. A fully domestic Indian module costs more than double a Chinese one without government support, and India's solar equipment import bill is projected to hit $30B annually by 2030, mostly from China, just to meet its own renewable targets.

Pharmaceuticals: India supplies 47% of all generic drugs dispensed in US pharmacies by volume. China supplies just 3.5% not because it lacks the manufacturing capacity, but because it has not prioritised the market. That changes if US-China relations normalise. China removed its 30% import duty on Indian medicines in September 2025 while simultaneously raising tariffs on US-branded drugs to 125% signalling it understands exactly where the market opportunity is. If China decides to compete directly in finished generic exports to the US, even capturing 10-15% of the market from near zero would materially compress Indian pharma margins in its single most important destination.

Semiconductors: The entire ₹1.60 lakh crore investment wave, Tata-PSMC Dholera ($10.96B), Micron Gujarat ($2.75B), Adani-Tower Maharashtra ($10B), Tata TSAT Assam ($3.25B) is explicitly driven by US-China decoupling and Taiwan strait risk, not organic market demand. The Dholera fab targets 28nm-110nm chips, the same mature segments where China's SMIC already competes aggressively. First commercial silicon is targeted 2027-28, If chip restrictions ease before that, India's capacity enters the market against Chinese cost and ecosystem advantages it cannot match, while the government carries 50% of capex exposure on every approved project.

Geopolitical Issues: If US-China relations normalise, India's geopolitical position, already complicated, becomes structurally more vulnerable overnight.

China's territorial pressure on India is not speculative it is ongoing and documented:

Claims over 90,000 sq km of Arunachal Pradesh as "South Tibet" and administers 38,000 sq km of Aksai Chin that India considers its own
PLA troops advanced at least 60km into Arunachal Pradesh in 2024
Six consecutive batches of renamed Indian locations released since 2017, a sustained cartographic campaign
Civilian settlements built along the Line of Actual Control, legally empowered under a 2022 Chinese law to support military border operations

The encirclement of India through its neighbours is equally deliberate:

Pakistan — owes China $29 billion, sources 80%+ of its arms from Chinese suppliers, hosts CPEC running through territory India claims
Bangladesh — new government secured $2.1 billion in Chinese investment in March 2025, including $400 million into Mongla Port weeks after India’s operating rights got stalled
Sri Lanka — China holds a 99-year lease on Hambantota Port
Maldives — China signed a security agreement in 2024
Myanmar — Chinese naval access through Kyaukpyu Port, bringing the PLA Navy to India's eastern flank

India's current position economically and geopolitical is built less on what it has built and more on China being penalised. The manufacturing boom, the FDI inflows, the strategic partnerships with Washington: all of it runs on a geopolitical subsidy that is a policy variable, not a permanent condition. In smartphones, solar, and semiconductors, lower restrictions on China directly compress India's advantage. In pharmaceuticals, the risk is China entering the finished product market India spent 30 years building.

On the border, in the neighbourhood, and in the diplomatic corridors where India's strategic value is currently priced, that value peaks the moment the US most needs an alternative to China, and recedes the moment it doesn't. Russia is no longer the balancing lever it once was. The neighbours are already shifting. The window is real, but it is not indefinitely open and the lesson from China's own history is that the countries which endure are the ones that used moments like this to build something that outlasts the conditions that created them. India has the window. The question is execution velocity.

Sources